LLY
759.75
-0.52%↓
JNJ
176.59
+0.08%↑
ABBV
220.03
+1.83%↑
UNH
341.1
+0.38%↑
AZN
77.6
-0.01%↓
LLY
759.75
-0.52%↓
JNJ
176.59
+0.08%↑
ABBV
220.03
+1.83%↑
UNH
341.1
+0.38%↑
AZN
77.6
-0.01%↓
LLY
759.75
-0.52%↓
JNJ
176.59
+0.08%↑
ABBV
220.03
+1.83%↑
UNH
341.1
+0.38%↑
AZN
77.6
-0.01%↓
LLY
759.75
-0.52%↓
JNJ
176.59
+0.08%↑
ABBV
220.03
+1.83%↑
UNH
341.1
+0.38%↑
AZN
77.6
-0.01%↓
LLY
759.75
-0.52%↓
JNJ
176.59
+0.08%↑
ABBV
220.03
+1.83%↑
UNH
341.1
+0.38%↑
AZN
77.6
-0.01%↓
24h
Šī brīža
Min
5.97
Max
6.23
Ienākumi | -14M -37M |
---|---|
Pārdošana | 7.9M 38M |
EPS | -4.07 |
Peļņas marža | -98.215 |
Darbinieki | 279 |
EBITDA | 8.9M -24M |
Rekomendācijas | Pirkt |
---|---|
Prognoze 12 mēnešiem | +191.53% upside |
Tirgus kapitalizācija | 21M 56M |
---|---|
Iepriekšējā atvēršanas cena | 7.53 |
Iepriekšējā slēgšanas cena | 6.07 |
By Acuity
50%
50%
185 / 371 Rangs Healthcare
By Trading Central
Pārliecība
Bullish Evidence
5.9501 / 7.66 Atbalsts un pretestība
Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.
2025. g. 16. sept. 17:03 UTC
BrainsWay Shares Rise on FDA Clearance of Major Depressive Disorder Treatment
DJ
Lasīt
2025. g. 16. sept. 16:49 UTC
GD Culture Shares Drop After Deal for Pallas Capital
DJ
Lasīt
2025. g. 16. sept. 16:11 UTC
Corbus Shares Rise on FDA Fast-Track Designation for Cancer Drug
DJ
Lasīt
2025. g. 16. sept. 23:40 UTC
Nikkei May Decline as Yen Strengthens -- Market Talk
DJ
Lasīt
2025. g. 16. sept. 23:34 UTC
Gold Edges Higher Ahead of FOMC Decision -- Market Talk
DJ
Lasīt
2025. g. 16. sept. 23:20 UTC
Restaurant Brands NZ Can Outperform When Cycle Turns -- Market Talk
DJ
Lasīt
2025. g. 16. sept. 21:10 UTC
U.S. Investors, Trump Close In on TikTok Deal With China -- WSJ
DJ
Lasīt
2025. g. 16. sept. 20:51 UTC
U.S. Home Sales, New Home Listings Fall in August -- Market Talk
DJ
Lasīt
2025. g. 16. sept. 20:50 UTC
Energy & Utilities Roundup: Market Talk
DJ
Lasīt
2025. g. 16. sept. 20:50 UTC
Basic Materials Roundup: Market Talk
DJ
Lasīt
2025. g. 16. sept. 20:25 UTC
The AI Trade Has Stocks Near Highs Again. Some Tech Names Remain on the Sidelines -- Barrons.com
DJ
Lasīt
2025. g. 16. sept. 20:24 UTC
These Stocks Moved the Most Today: Oracle, Tesla, Alphabet, Dave & Buster's, Chipotle, and More -- Barrons.com
DJ
Lasīt
2025. g. 16. sept. 19:19 UTC
U.S. Natural Gas Futures Extend Winning Streak -- Market Talk
DJ
Lasīt
2025. g. 16. sept. 18:52 UTC
Oil Futures Advance on Russia Concerns, Weak Dollar -- Market Talk
DJ
Lasīt
2025. g. 16. sept. 18:44 UTC
Global Equities Roundup: Market Talk
DJ
Lasīt
2025. g. 16. sept. 18:44 UTC
EssilorLuxottica Well-Positioned in Growing Smart-Glasses Market -- Market Talk
DJ
Lasīt
2025. g. 16. sept. 18:40 UTC
Details Emerge on U.S.-China TikTok Deal -- WSJ
DJ
Lasīt
2025. g. 16. sept. 18:38 UTC
Meta Seen With Long-Term Opportunity to Lead in Smart Glasses -- Market Talk
DJ
Lasīt
2025. g. 16. sept. 18:19 UTC
Gold Settles at New High Ahead of Fed Decision -- Market Talk
DJ
Lasīt
2025. g. 16. sept. 18:01 UTC
U.S. Dollar Weakness Supports Oil's Gains -- Market Talk
DJ
Lasīt
2025. g. 16. sept. 17:34 UTC
Any Question the Bank of Canada Will Cut Now Look to Have Vanished -- Market Talk
DJ
Lasīt
2025. g. 16. sept. 16:53 UTC
Software Companies Are Fighting Back With AI. The Stocks Are Still Hurting. -- Barrons.com
DJ
Lasīt
2025. g. 16. sept. 16:20 UTC
Basic Materials Roundup: Market Talk
DJ
Lasīt
2025. g. 16. sept. 16:15 UTC
Global Commodities Roundup: Market Talk
DJ
Lasīt
2025. g. 16. sept. 16:09 UTC
Global Energy Roundup: Market Talk
DJ
Lasīt
2025. g. 16. sept. 16:09 UTC
Canada Industry Minister to Meet Mining CEOs on Merger -- Market Talk
DJ
Lasīt
2025. g. 16. sept. 15:35 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Lasīt
2025. g. 16. sept. 15:35 UTC
Gold Soars Past $3,700 Ahead of Fed Decision -- Market Talk
DJ
Lasīt
2025. g. 16. sept. 15:22 UTC
More Investors Think Dollar is Overvalued in Latest BofA Survey -- Market Talk
DJ
Lasīt
2025. g. 16. sept. 15:21 UTC
Sterling Considered Most Overvalued in Nearly 10 Years -- Market Talk
DJ
Lasīt
Cenas izmaiņa
By TipRanks
Prognoze 12 mēnešiem
Vidējais 18.25 USD 191.53%
Augstākais 30 USD
Zemākais 8 USD
Pamatojoties uz 5 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Karyopharm Therapeutics Inc — pēdējo 3 mēnešu laikā.
By TipRanks
Pirkt
5 ratings
3
Pirkt
2
Turēt
0
Pārdot
Pamatojoties uz 5 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Karyopharm Therapeutics Inc — pēdējo 3 mēnešu laikā.
By Trading Central
Īstermiņā
Bullish Evidence
Recent bullish events outweigh bearish events.
Vidējā termiņā
Strong Bearish Evidence
All events are bearish.
Ilgtermiņā
No Evidence
There are no events.
By Acuity
Ziņu noskaņojums
Neutral
Volatilitāte
Zem vidējā
Ziņu apjoms (RCV)
Virs vidējā
Pārdošanas un administrēšanas izmaksas
Darbības izmaksas
Peļņa pirms nodokļu nomaksas
Pārdošana
Pārdošanas maksa
Bruto peļņa no pārdošanas
Procentu izdevumi par parādu
EBITDA
Pamatdarbības peļņa
$